Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A cytoplasmic protein, NfrC, is required for bacteriophage N4 adsorption.
Budd-Chiari syndrome: CT observations.
Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia. N Engl J Med. 2016 Aug 25; 375(8):740-53.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Female
Humans
Intention to Treat Analysis
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Remission Induction
Sialic Acid Binding Ig-like Lectin 2
Survival Analysis
Young Adult
authors with profiles
Wendy Stock